Literature DB >> 31451336

The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion.

Maciej Banach1, Eric Bruckert2, Olivier S Descamps3, Lars Ellegård4, Marat Ezhov5, Bernhard Föger6, Zlatko Fras7, Petri T Kovanen8, Gustavs Latkovskis9, Winfried März10, Demosthenes B Panagiotakos11, György Paragh12, Daniel Pella13, Angela Pirillo14, Andrea Poli15, Željko Reiner16, Günter Silbernagel17, Margus Viigimaa18, Michal Vrablík19, Alberico L Catapano20.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31451336     DOI： 10.1016/j.atherosclerosissup.2019.08.023

Source DB:  PubMed          Journal:  Atheroscler Suppl        ISSN： 1567-5688            Impact factor:   3.235


× No keyword cloud information.
  8 in total

1.  PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021.

Authors:  Maciej Banach; Paweł Burchardt; Krzysztof Chlebus; Piotr Dobrowolski; Dariusz Dudek; Krzysztof Dyrbuś; Mariusz Gąsior; Piotr Jankowski; Jacek Jóźwiak; Longina Kłosiewicz-Latoszek; Irina Kowalska; Maciej Małecki; Aleksander Prejbisz; Michał Rakowski; Jacek Rysz; Bogdan Solnica; Dariusz Sitkiewicz; Grażyna Sygitowicz; Grażyna Sypniewska; Tomasz Tomasik; Adam Windak; Dorota Zozulińska-Ziółkiewicz; Barbara Cybulska
Journal:  Arch Med Sci       Date:  2021-11-08       Impact factor: 3.318

Review 2.  Curcumin - The Nutraceutical With Pleiotropic Effects? Which Cardiometabolic Subjects Might Benefit the Most?

Authors:  Stanisław Surma; Amirhossein Sahebkar; Jakub Urbański; Peter E Penson; Maciej Banach
Journal:  Front Nutr       Date:  2022-05-17

3.  Decreased Risk of Stroke in People Using Red Yeast Rice Prescriptions (LipoCol Forte®): a Total Population-Based Retrospective Cohort Study.

Authors:  Chuen-Chau Chang; Mao-Feng Sun; Yi-Chun Chou; Chun-Chieh Yeh; Chaur-Jong Hu; Yih-Giun Cherng; Ta-Liang Chen; Chien-Chang Liao
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-23       Impact factor: 2.650

4.  Efficacy and safety of xuezhikang once per day versus two times per day in patients with mild to moderate hypercholesterolaemia (APEX study): a protocol for a multicentre, prospective randomised controlled, open-label, non-inferiority study.

Authors:  Zexuan Wu; Dexi Wu; Jingzhou Jiang; Ailan Chen; Dong-Dan Zheng; Jianhao Li; Yugang Dong; Yili Chen
Journal:  BMJ Open       Date:  2020-05-17       Impact factor: 2.692

Review 5.  The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia.

Authors:  Peter E Penson; Maciej Banach
Journal:  Curr Atheroscler Rep       Date:  2020-09-18       Impact factor: 5.113

6.  The Activity of Ten Natural Extracts Combined in a Unique Blend to Maintain Cholesterol Homeostasis-In Vitro Model.

Authors:  Sara Ruga; Rebecca Galla; Claudia Penna; Claudio Molinari; Francesca Uberti
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

Review 7.  Red Yeast Rice Preparations Reduce Mortality, Major Cardiovascular Adverse Events, and Risk Factors for Metabolic Syndrome: A Systematic Review and Meta-analysis.

Authors:  Rong Yuan; Yahui Yuan; Lidan Wang; Qiqi Xin; Ya Wang; Weili Shi; Yu Miao; Sean Xiao Leng; Keji Chen; Weihong Cong
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.810

8.  Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia.

Authors:  Maciej Banach; Niki Katsiki; Gustavs Latkovskis; Manfredi Rizzo; Daniel Pella; Peter E Penson; Zeljko Reiner; Arrigo F G Cicero
Journal:  Arch Med Sci       Date:  2021-03-04       Impact factor: 3.318
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.